After being one of the leading tycoons supporting the Democrats to remain in the White House, billionaire Mark Cuban has now chosen to praise Donald Trump's strategy to make medicines cheaper in the United States.

In 2024, the shrewd Pennsylvania investor decided He distanced himself from the Republicans, whom he had supported for years, and instead chose to participate in some fundraising events for Joe Biden's Democratic candidacy. "If they were having his last wake, and it was him against Trump, and they were giving him the last rites, he would still vote for Joe Biden," he said. However, almost two years later, Cuban acknowledges the work done by the Trump administration to lower drug prices through the TrumpRX platform, which was launched last month. "Everyone wants me to criticize TrumpRx. The reality is that it saves patients money on IVF treatments and other medications. A lot of money. In my opinion, anything that saves patients money is a win," Cuban wrote on the platform X, formerly known as Twitter. TrumpRX offers discounted prices for 54 prescription drugs, including those used to treat conditions such as diabetes, arrhythmias, heartburn and fertility.

The key to achieving lower prices lies in the fact that the drugs are brand-name versions marketed directly, cutting out intermediaries.

Although TrumpRX does not sell drugs directly, it functions as an information portal where people can find coupons and cheap prices on widely used brand-name medications for treating chronic illnesses.

“Drug prices in the United States will drop dramatically and will soon be the lowest in the developed world,” the president predicted in December.

To achieve this goal,It offered tariff exemptions for at least three years, provided that commitments to keep prices low are met. The list of pharmaceutical companies willing to collaborate with the government includes: Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi.